Phase I trial assesses new ruthenium-based anticancer agent NKP-1339 in advanced solid tumors July 1, 2011
FDA accepts for review Pfizer's application for axitinib in advanced renal cell carcinoma June 30, 2011
Phase I trial assesses TPI-287 with and without temozolomide in neuroblastoma/medulloblastoma June 30, 2011
BioAlliance Pharma submits application to French Drug Agency for phase III Livatag trial June 30, 2011
RSS